![Matthew Pulisic](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 839 507 $ al 30/06/2026
Matthew Pulisic is currently Chief Financial & Accounting Officer at Genelux Corp.
since 2025.
Formerly, Mr. Pulisic was Vice President-Finance at Arrowhead Pharmaceuticals, Inc. from 2020 to 2025.
Education includes an undergraduate degree from the University of California, Santa Cruz and an MBA from California Lutheran University School of Business Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GENELUX CORP. 0,62 % | 16/06/2026 | 278.906 ( 0,62 % ) | 839 507 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GENELUX CORPORATION | Director Financiero/CFO | 30/01/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/01/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Genelux Corp.
 Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
University of California, Santa Cruz
 University of California, Santa Cruz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Lutheran University School of Business Management
 California Lutheran University School of Business Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
